# iCeutica

Startup profile on Capital Atlas: https://capitalatlas.ai/startups/iceutica

- Industry: Pharmaceuticals
- Headquarters: Princeton, US
- Website: www.iceutica.com
- Total disclosed funding: $2.5M
- Latest round: Series D (Mar 16, 2011)
- Investors on record: 2

## About

Based in New Jersey, US, and founded in 2011 by Liddy McCall,  iCeutica Inc is a pharmaceutical research and development company that uses technology to improve pharmaceutical performance by altering how the drug dissolves and gets absorbed. In March 2011, iCeutica Inc raised USD 1.01 million in Series D funding from Inventages Venture Capital and other investors. The company’s partners include Iroko Pharmaceuticals and Churchill Pharmaceuticals. 

The company employs a proprietary SoluMatrix™ Fine Particle Technology to develop new pharmaceuticals that integrate performance-enhancement of drug products through analytical analysis, method development, prototyping, and manufacturing capabilities, and it provides enhanced drug development capabilities for drugs such as pain relievers, oncology treatment drugs, and respiratory diseases. The firm’s products include Zorvolex™, Tivorbex™, and Vivlodex™, and prostate cancer drug Yonsa®.

## Funding rounds

- Series D, Mar 16, 2011, $1M — Inventages Venture Capital
- Series B, Dec 20, 2006, $0.5M — PIPV Capital
- Series A, Jun 22, 2005, $1M — PIPV Capital

## Investors

- PIPV Capital (https://capitalatlas.ai/funds/pipv-capital) — Series A, Series B
- Inventages Venture Capital (https://capitalatlas.ai/funds/inventages-venture-capital) — Series D